Copyright
©The Author(s) 2021.
World J Clin Cases. Mar 26, 2021; 9(9): 2110-2122
Published online Mar 26, 2021. doi: 10.12998/wjcc.v9.i9.2110
Published online Mar 26, 2021. doi: 10.12998/wjcc.v9.i9.2110
Table 8 Consensus statement of Chinese experts on pain treatment with transdermal patch
Consensus opinion | Recommended strength level of evidence |
The effect of the transdermal patch in pain treatment is clear. It has the advantages of reducing adverse drug reactions and improving patient compliance | 1A |
NSAID transdermal patch is effective in the treatment of chronic skeletal muscle pain with few side effects, which is recommended as the first choice for the treatment of chronic musculoskeletal pain | 1A |
NSAIDs can be used as a combination therapy for neuropathic pain | 2C |
When the efficacy of transdermal NSAIDs alone is not good enough, which can be combined with analgesic drugs of another administration route, such as oral NSAIDs | 2B |
Opioid transdermal patch is effective in the treatment of chronic pain, but it should not be used as the initial treatment for chronic pain due to addiction and adverse reactions | 1B |
Opioid transdermal patch should not be used in the treatment of acute or breakthrough pain | 1A |
When other first-line treatment drugs are ineffective, 8% capsaicin patch can be considered for chronic pain related to peripheral neuropathic pain | 1B |
When other first-line treatment drugs are ineffective, 5% lidocaine patch can be considered for chronic pain related to peripheral neuropathic pain | 2B |
- Citation: Ma K, Jiang W, Wang YX, Wang L, Lv Y, Liu JF, Liu RG, Liu H, Xiao LZ, Du DP, Lu LJ, Yang XQ, Xia LJ, Huang D, Fu ZJ, Peng BG, Liu YQ. Expert consensus of the Chinese Association for the Study of Pain on pain treatment with the transdermal patch. World J Clin Cases 2021; 9(9): 2110-2122
- URL: https://www.wjgnet.com/2307-8960/full/v9/i9/2110.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i9.2110